Impact of serum amyloid A on cellular cholesterol efflux to serum in type 2 diabetes mellitus.

[1]  Zahi A Fayad,et al.  Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport. , 2012, Circulation.

[2]  R. Birner-Gruenberger,et al.  Uremia alters HDL composition and function. , 2011, Journal of the American Society of Nephrology : JASN.

[3]  V. King,et al.  Serum amyloid A in atherosclerosis , 2011, Current opinion in lipidology.

[4]  A. Vaughan,et al.  ATP binding cassette G1-dependent cholesterol efflux during inflammation1 , 2011, Journal of Lipid Research.

[5]  Robert L Wilensky,et al.  Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. , 2011, The New England journal of medicine.

[6]  P. Heeringa,et al.  Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A2[S] , 2010, Journal of Lipid Research.

[7]  K. Tan,et al.  Cellular cholesterol efflux to serum is impaired in diabetic nephropathy , 2008, Diabetes/metabolism research and reviews.

[8]  N. Webb,et al.  HDL cholesterol transport during inflammation , 2007, Current opinion in lipidology.

[9]  J. Raynes,et al.  The lipidation status of acute-phase protein serum amyloid A determines cholesterol mobilization via scavenger receptor class B, type I. , 2007, The Biochemical journal.

[10]  S. Umemura,et al.  Serum amyloid A is a better predictor of clinical outcomes than C-reactive protein in non-ST-segment elevation acute coronary syndromes. , 2007, Circulation journal : official journal of the Japanese Circulation Society.

[11]  K. Gaus,et al.  Roles of ATP binding cassette transporters A1 and G1, scavenger receptor BI and membrane lipid domains in cholesterol export from macrophages , 2006, Current opinion in lipidology.

[12]  I. Gelissen,et al.  ABCA1 and ABCG1 Synergize to Mediate Cholesterol Export to ApoA-I , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[13]  M. Mussap,et al.  Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes. , 2005, Journal of the American Society of Nephrology : JASN.

[14]  Chang Yeop Han,et al.  Thematic review series : The Immune System and Atherogenesis Lipoprotein-associated inflammatory proteins : markers or mediators of cardiovascular disease ? , 2005 .

[15]  F. D. de Beer,et al.  Serum Amyloid A Is a Ligand for Scavenger Receptor Class B Type I and Inhibits High Density Lipoprotein Binding and Selective Lipid Uptake* , 2005, Journal of Biological Chemistry.

[16]  H. Brewer,et al.  Serum amyloid A promotes ABCA1-dependent and ABCA1-independent lipid efflux from cells. , 2004, Biochemical and biophysical research communications.

[17]  M. Connelly,et al.  Scavenger Receptor Class B Type I-mediated Cholesteryl Ester-selective Uptake and Efflux of Unesterified Cholesterol , 2004, Journal of Biological Chemistry.

[18]  S. Reis,et al.  Serum Amyloid A as a Predictor of Coronary Artery Disease and Cardiovascular Outcome in Women: The National Heart, Lung, and Blood Institute–Sponsored Women’s Ischemia Syndrome Evaluation (WISE) , 2004, Circulation.

[19]  S. Tam,et al.  Promoting export of macrophage cholesterol: the physiological role of a major acute-phase protein, serum amyloid A 2.1. , 2002, Journal of lipid research.

[20]  K. Feingold,et al.  Cholesterol efflux by acute-phase high density lipoprotein: role of lecithin: cholesterol acyltransferase. , 2001, Journal of lipid research.

[21]  J. Mcneish,et al.  The Correlation of ATP-binding Cassette 1 mRNA Levels with Cholesterol Efflux from Various Cell Lines* , 2000, The Journal of Biological Chemistry.

[22]  S. Lestavel,et al.  Role of serum amyloid A during metabolism of acute-phase HDL by macrophages. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[23]  M. A. Crook,et al.  Is Type II diabetes mellitus a disease of the innate immune system? , 1998, Diabetologia.

[24]  J. Raynes,et al.  Serum amyloid A has little effect on high density lipoprotein (HDL) binding to U937 monocytes but may influence HDL mediated cholesterol transfer. , 1997, Biochemical Society transactions.

[25]  M. Taskinen,et al.  Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein. , 1996, Atherosclerosis.

[26]  L. Curtiss,et al.  Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux. , 1995, Journal of lipid research.

[27]  G. Coetzee,et al.  Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition. , 1986, The Journal of biological chemistry.

[28]  K. Sletten,et al.  Characterization of amyloid related protein SAA complexed with serum lipoproteins (apoSAA). , 1982, Clinical and experimental immunology.

[29]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[30]  P. Kovanen,et al.  Immune functions of serum amyloid A. , 2012, Critical reviews in immunology.

[31]  M. Nieminen,et al.  Cholesterol efflux capacity in vitro predicts the severity and extent of coronary artery disease in patients with and without type 2 diabetes. , 2001, Scandinavian cardiovascular journal : SCJ.